Translate Bio, Inc.
DelistedCIK 1693415fmd_0J5MFFAVFBZHW9HP70WPRHS60YManufacturing · Biological Products, (No Diagnostic Substances)Template: Standard
Coverage: Jan 01, 2017 to Jun 30, 2021, 18 periods
| Line item | FY2017 | FY2018 | FY2019 | FY2020 |
|---|---|---|---|---|
| Total revenues | – | 1 | 8 | 139 |
| Research and development | 47 | 58 | 76 | 110 |
| Total operating expenses | 79 | 106 | 124 | 194 |
| Operating income | (79) | (104) | (116) | (55) |
| Interest and investment income | 0 | 1 | 2 | – |
| Other non-operating income (expense) | 0 | 1 | 2 | 2 |
| Income before taxes | (79) | (103) | (114) | (54) |
| Income tax expense | (12) | (6) | (0) | – |
| Net income from continuing operations | (66) | (97) | (113) | – |
| Net income | (66) | (97) | (113) | (54) |
| Net income to common shareholders | (67) | (98) | (113) | – |